-IANS A parliamentary panel has invited actor Aamir Khan, who exposed malpractice in the medical sector on his "Satyamev Jayate" TV programme, for an interaction on the issue. He will appear on Thursday morning with his team. Rajya Sabha MP Shanta Kumar of the Bharatiya Janata Party, who heads the parliamentary standing committee on commerce, has invited the actor to share knowledge they gained while researching the episode. Aamir's spokesperson confirmed to IANS...
More »SEARCH RESULT
ACTA will make Life Saving Drugs costlier for the poor-Rachit Ranjan
Joseph Munyi, a Kenyan citizen, has been living with HIV for 8 years and, much like other HIV patients, is unemployed. He has been receiving his medication free of charge on account of government programmes and outreach programmes of Medicine Sans Frontieres. His medication comes in the form of generic drugs. However, this situation may not last long as economic interests of few may end up impeding many a public spirited...
More »Health ministry underplays parliamentary panel report-Vidya Krishnan
A key finding in the report was that several multinational firms had launched drugs without conducting mandatory clinical trials or seeking expert medical opinion The health ministry has denied the presence of any systemic rot in the drug approval process and pharmaceutical firms have refuted charges of collusion after a report by a parliamentary panel pointed to regulatory lapses in clinical trials. The panel, which looked into the functioning of Central Drugs...
More »Drug cos lay onus of medicine approvals at DCGI door-step
-The Hindu Business Line The onus of granting approvals to medicines marketed in the country is on the regulator Drug Controller General of India (DCGI), say drug companies, adding that they have adhered to the law of the land. The drug-makers were responding to a Parliamentary panel report on health that severely indicted the drug regulatory authority, besides alleging that “invisible hands” of drug-makers were involved in getting favourable reports on medicines...
More »Patent to plunder -Amit Sengupta
India's efforts to produce and supply life-saving drugs at affordable prices face challenges from multinational companies trying to “evergreen” their patents. THE average life expectancy across the globe has increased from around 30 years a century ago to over 65 years today. This has been made possible in large part by modern medicine. Never before in history have humans had access to such an array of medicines and devices to...
More »